Statistics

Total Visits

Views
Long-Term (52-Week) Results Of a Phase 3, Randomized, Controlled Trial Of Apremilast, An Oral Phosphodiesterase 4 Inhibitor, In Patients With Psoriatic Arthritis and Current Skin Involvement (PALACE 3)75

Select a period of time:

Number of views in the range

Views
Long-Term (52-Week) Results Of a Phase 3, Randomized, Controlled Trial Of Apremilast, An Oral Phosphodiesterase 4 Inhibitor, In Patients With Psoriatic Arthritis and Current Skin Involvement (PALACE 3)24

Views

Views
November 20256
December 20252
January 20262
February 20262
March 20261
April 20268
May 20263
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States9
Brazil2
Chile2
Ecuador2
Mexico2
Australia2
Germany1
France1
United Kingdom1
Hong Kong1
 

Top cities views

Views
San Jose6
Santiago2
Mexico City2
Barquisimeto1
Beaumont1
Cuenca1
Hamilton1
Los Angeles1
Medianeira1
Milagro1